Bioinformatics for Drug Discovery and Development
- 27th February 2026
- Posted by: Breige McBride
- Category: Uncategorised
If you are looking for a bioinformatics provider that works with you to reach your drug development goals, Fios Genomics can help. We specialise in bioinformatics for drug discovery and development, enabling us to guide your program from wherever it is currently, to market submission.
We Take You Beyond Bioinformatics
Biological expertise
Both our business development team and our bioinformaticians come from biological backgrounds. This means they can fully grasp your research and its goals. Since our bioinformaticians have biological backgrounds, they (and the data analysis reports they provide) go beyond what your data means statistically, explaining your data in its biological context and how it relates to your overall research goal. We have experience at every stage of the process, from development and pre-clinical studies through to the clinic.
Before performing any analyses, we will have a call with you to understand your research and it’s goals, and to provide advice relevant to whatever of the research process you are at. For example, we can advise on study design, ensuring your research question is at the centre of your experimental design so the right output can be generated to provide the answers you wish to uncover.
Drug discovery and development expertise
At Fios Genomics, we have deep understanding of the drug discovery and development process. Everyone in the company understands this process, but we also have much deeper expertise within the team where it is most valuable to our clients. For example, our business development team, who are the first point of contact with anyone looking to engage our services, are well-equipped to understand both the biological and commercial challenges our clients face, due to their biological backgrounds in both academia and industry. Roles our team have previously held include Study Directors, Head of Preclinical Development, R&D Team Managers and NGS specialists.
Data integration expertise
Our ability to analyse ’omic, non-omic and metadata (including complex multi-omics datasets) enables us to uncover the full biological story within your data and translate it into insights that support critical drug development decisions. By integrating diverse data types and examining them as a whole, we generate findings that are comprehensive, contextual and actionable. This approach ensures relevant insights are not overlooked, strengthens target validation and preclinical rationale, and helps advance your program from discovery through key development milestones with greater confidence and reduced risk.
These three areas of expertise are what enable us to specialise in bioinformatics for drug discovery and development. They are also why the majority of our clients come from biotech and pharma. For example, some of the companies we have worked with include: Alligator Bioscience, G1 Therapeutics, Genentech, Roche and Syndax Pharmaceuticals.
Benefits of Working with Fios Genomics
Expert support
You can rely on our proven drug development expertise across all development stages, from concept to clinic.
Biological insights
When you work with us you will receive a clear biological narrative supported by an interactive data analysis report. After you have reviewed the report, we will walk you through the findings during a review call and answer any questions.
Confident conclusions
Our analyses will give you greater confidence in your study conclusions.
Evidence-based decision-making
Our results provide strong evidence for publications, decision-making and investment strategies.
Know your next step
Our deep analysis result interpretation reveals the natural next step of your research.
Want an informal, no-obligation discussion about your drug discovery or development research and how we can help? Just fill out the form below and we’ll be in touch to arrange a chat.
Author: Breige McBride, Marketing Manager, Fios Genomics
Reviewed by Fios Genomics Bioinformatics Experts to ensure accuracy
See also:
Why do gene therapies cost so much?
How to unblock the drug development pipeline
